Industry Growth Insights published a new data on “POC HbA1C Testing Market”. The research report is titled “POC HbA1C Testing Market research by Types (Immunoassay, Boronate Affinity, Others, POC HbA1C Testin), By Applications (Hospital & Clinics, Diagnostic Laboratories, Other), By Players/Companies Abbott, Roche, Bio-Rad, Siemens, GREEN CROSS MEDIS, Trinity Biotech, HUMAN Diagnostics, PTS Diagnostics, Erba Diagnostics, EKF Diagnostics, OSANG Healthcare, POC HbA1C Testin”.
Scope Of The Report
Report Attributes
Report Details
Report Title
POC HbA1C Testing Market Research Report
By Type
Immunoassay, Boronate Affinity, Others, POC HbA1C Testin
By Application
Hospital & Clinics, Diagnostic Laboratories, Other
By Companies
Abbott, Roche, Bio-Rad, Siemens, GREEN CROSS MEDIS, Trinity Biotech, HUMAN Diagnostics, PTS Diagnostics, Erba Diagnostics, EKF Diagnostics, OSANG Healthcare, POC HbA1C Testin
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global POC HbA1C Testing Market Report Segments:
The global POC HbA1C Testing market is segmented on the basis of:
Types
Immunoassay, Boronate Affinity, Others, POC HbA1C Testin
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital & Clinics, Diagnostic Laboratories, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Roche
- Bio-Rad
- Siemens
- GREEN CROSS MEDIS
- Trinity Biotech
- HUMAN Diagnostics
- PTS Diagnostics
- Erba Diagnostics
- EKF Diagnostics
- OSANG Healthcare
- POC HbA1C Testin
Highlights of The POC HbA1C Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Immunoassay
- Boronate Affinity
- Others
- POC HbA1C Testin
- By Application:
- Hospital & Clinics
- Diagnostic Laboratories
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the POC HbA1C Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
POC HbA1C testing is a blood test that measures the average blood sugar level over the past two to three months. POC HbA1C testing can help identify if someone has diabetes, and can also be used to monitor treatment progress.
Some of the key players operating in the poc hba1c testing market are Abbott, Roche, Bio-Rad, Siemens, GREEN CROSS MEDIS, Trinity Biotech, HUMAN Diagnostics, PTS Diagnostics, Erba Diagnostics, EKF Diagnostics, OSANG Healthcare, POC HbA1C Testin.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. POC HbA1C Testing Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. POC HbA1C Testing Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. POC HbA1C Testing Market - Supply Chain
4.5. Global POC HbA1C Testing Market Forecast
4.5.1. POC HbA1C Testing Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. POC HbA1C Testing Market Size (000 Units) and Y-o-Y Growth
4.5.3. POC HbA1C Testing Market Absolute $ Opportunity
5. Global POC HbA1C Testing Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. POC HbA1C Testing Market Size and Volume Forecast by Type
5.3.1. Immunoassay
5.3.2. Boronate Affinity
5.3.3. Others
5.3.4. POC HbA1C Testin
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global POC HbA1C Testing Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. POC HbA1C Testing Market Size and Volume Forecast by Application
6.3.1. Hospital & Clinics
6.3.2. Diagnostic Laboratories
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global POC HbA1C Testing Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. POC HbA1C Testing Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global POC HbA1C Testing Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. POC HbA1C Testing Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global POC HbA1C Testing Demand Share Forecast, 2019-2026
9. North America POC HbA1C Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America POC HbA1C Testing Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America POC HbA1C Testing Market Size and Volume Forecast by Application
9.4.1. Hospital & Clinics
9.4.2. Diagnostic Laboratories
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America POC HbA1C Testing Market Size and Volume Forecast by Type
9.7.1. Immunoassay
9.7.2. Boronate Affinity
9.7.3. Others
9.7.4. POC HbA1C Testin
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America POC HbA1C Testing Demand Share Forecast, 2019-2026
10. Latin America POC HbA1C Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America POC HbA1C Testing Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America POC HbA1C Testing Market Size and Volume Forecast by Application
10.4.1. Hospital & Clinics
10.4.2. Diagnostic Laboratories
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America POC HbA1C Testing Market Size and Volume Forecast by Type
10.7.1. Immunoassay
10.7.2. Boronate Affinity
10.7.3. Others
10.7.4. POC HbA1C Testin
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America POC HbA1C Testing Demand Share Forecast, 2019-2026
11. Europe POC HbA1C Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe POC HbA1C Testing Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe POC HbA1C Testing Market Size and Volume Forecast by Application
11.4.1. Hospital & Clinics
11.4.2. Diagnostic Laboratories
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe POC HbA1C Testing Market Size and Volume Forecast by Type
11.7.1. Immunoassay
11.7.2. Boronate Affinity
11.7.3. Others
11.7.4. POC HbA1C Testin
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe POC HbA1C Testing Demand Share, 2019-2026
12. Asia Pacific POC HbA1C Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific POC HbA1C Testing Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific POC HbA1C Testing Market Size and Volume Forecast by Application
12.4.1. Hospital & Clinics
12.4.2. Diagnostic Laboratories
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific POC HbA1C Testing Market Size and Volume Forecast by Type
12.7.1. Immunoassay
12.7.2. Boronate Affinity
12.7.3. Others
12.7.4. POC HbA1C Testin
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific POC HbA1C Testing Demand Share, 2019-2026
13. Middle East & Africa POC HbA1C Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa POC HbA1C Testing Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa POC HbA1C Testing Market Size and Volume Forecast by Application
13.4.1. Hospital & Clinics
13.4.2. Diagnostic Laboratories
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa POC HbA1C Testing Market Size and Volume Forecast by Type
13.7.1. Immunoassay
13.7.2. Boronate Affinity
13.7.3. Others
13.7.4. POC HbA1C Testin
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa POC HbA1C Testing Demand Share, 2019-2026
14. Competition Landscape
14.1. Global POC HbA1C Testing Market: Market Share Analysis
14.2. POC HbA1C Testing Distributors and Customers
14.3. POC HbA1C Testing Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Roche
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Bio-Rad
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Siemens
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. GREEN CROSS MEDIS
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Trinity Biotech
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. HUMAN Diagnostics
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. PTS Diagnostics
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Erba Diagnostics
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. EKF Diagnostics
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. OSANG Healthcare
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. POC HbA1C Testin
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
